thereby supporting the program’s potential to address a broad cancer patient population. Immatics’ PRAME peptide is present at a high copy number per tumor cell and is homogeneously and ...
Assessing Microenvironment Immunogenicity Using Tumor Specimen Exomes: Co-detection of TcR-α/β V(D)J Recombinations Correlates with PD-1Expression This is the first report of any unproductive ...
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...
Cancer Research & Immuno-Oncology Week 2022 will offer a 3-day content-rich program providing invited lectures, thought-provoking discussions, and posters to explore global developments and ...
Umoja’s poster presentation will provide a further update on UB-VV111’s favorable safety and biodistribution profile. Details of the oral and poster presentations can be found below: Oral Presentation ...
Society for Immunotherapy of Cancer (SITC) 2023 poster. 3 Paston, et al (2024). A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced ...
Andhra Pradesh government to launch State-wide cancer screening drive for early detection and prevention, targeting breast, oral, and cervical cancers.
Disgraced Hollywood producer Harvey Weinstein is back in the hospital and now plans to sue New York City over “ongoing ...
A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...
Imvax, Inc. today announced an oral presentation and two poster presentations at the 2024 SNO Annual Meeting in Houston, Texas.
Oral presentation of long term follow-up from patients ... non-small cell lung cancer and pancreatic cancer. The first poster presented described Cogent’s internally-developed pan KRAS(ON) inhibitor ...
14d
Late-breaking abstract featuring IGNYTE clinical trial data, including subgroup and initial biomarker analyses, selected for oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback